New report exposes gaps in affordable healthcare
The race to develop new medicines is accelerating, but millions of patients in low- and middle-income countries remain unable to access essential treatment due to high costs, limited availability and weak healthcare systems. The 2026 Access to Medicine Index, which assesses 20 leading pharmaceutical companies, shows that while companies are increasingly considering access earlier in […]
We haven't written up this one. People Daily Kenya has the full story — the link below goes straight to it.
